Amylin Pharmaceuticals

Amylin Pharmaceuticals, a wholly-owned subsidiary of Bristol-Myers Squibb, is dedicated to the discovery, development, and commercialization of pharmaceuticals, with a focus on developing a range of diagnostic and therapeutic products for diabetes.